Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 1

HCV Genotype Distribution of Patients with Chronic Hepatitis C in Istanbul

Sayfa
86–92
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, 2.9% of HCV mixed genotype was detected and this should be considered concerning management of HCV infection.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Hepatitis C virus (HCV), which has no protective vaccine, is a common cause of chronic hepatitis, which is a severe public health threat.
📊
Temel Bulgular & Veri:In Turkey, the preva- lence of genotype 1 is between 51.7% and 97.1%, the highest rate among all genotypes, while subtype 1b is the genotype with the highest rate.
💡
Sonuç & Katkı:In addition, 2.9% of HCV mixed genotype was detected and this should be considered concerning management of HCV infection.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Hepatitis C virus (HCV), which has no protective vaccine, is a common cause of chronic hepatitis, which is a severe public health threat. There are differences in nucleotide and amino acid sequences in different regions of the HCV genome. As a result of these differences, HCV has been shown to have at least seven major genotypes and many subtypes. In Turkey, the preva- lence of genotype 1 is between 51.7% and 97.1%, the highest rate among all genotypes, while subtype 1b is the genotype with the highest rate. It is important to detect mixed genotype infection reliably as it causes treatment failure. This study aims to reveal the distribution of the HCV genotypes in our hospital in Istanbul over the years and to contribute to the epidemiological data of Turkey. Methods: For this purpose, 385 patient samples sent to Sisli Hamidiye Etfal Training and Research Hospital, Clinical Microbiology Laboratory for HCV genotype determination between January 2016 and June 2019 were evaluated retrospectively. Anti-HCV was screened by enzyme immunoassay and confirmation was performed by Line immunoassay. HCV genotyping assays targeting highly conserved 5’UTR and most variable region NS5B regions were used. Results: The most common genotype was genotype 1 (81.3%) with 313 cases and subtypes 1a and 1b were detected at the rates of 10.9% and 67.8%, respectively. In addition, genotype 3, 2, 4, 5 were detected at the rates of 8.8%, 3.4%, 2.9%, 0.8%, respectively and mixed genotype was found in 2.9% of cases. Although genotype 5 is seen in South Africa, it is found in the Middle East region, albeit at a low rate. In our study, it was observed that genotype 5 was detected in different years from patients of Syrian origin. Conclusion: In this study, genotype 1 was the most common genotype with a rate of 81.3% and subtype 1b was 67.8%, in accor- dance with the literature. However, genotypes 3, 2, 4 and 5 were also present at low rates. It is important to monitor these rare genotypes since some of them are dominant in surrounding countries. In addition, 2.9% of HCV mixed genotype was detected and this should be considered concerning management of HCV infection.

🔖

Bu Makaleye Atıf Yap

BULUT, M. E., TOPALCA, U. S., MURAT, A., TEKE, L., CANALP, H. Z., OCAL, M., BAYRAKTAR, B. (2021). HCV Genotype Distribution of Patients with Chronic Hepatitis C in Istanbul. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 1, 86–92. https://ajindex.com/articles/402855

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Selek MB, Baylan O, Karagöz E, Özyurt M. Changes in hepatitis C virus genotype distribution in chronic hepatitis C infection pa- tients. Indian J Med Microbiol 2018;36:416–21
  2. Farci P. New insights into the HCV quasispecies and compartmen- talization. Semin Liver Dis 2011;31:356–74
  3. Kulah C, Altindis M, Akyar I, Gokahmetoglu S, Sayiner A, Kaleli I, et al. The prevalence of mixed genotype infections in Turkish patients with hepatitis C: a multicentered assessment. Clin Lab 2019;65
  4. Ergünay K, Abacıoğlu H. Clinical impact of hepatitis C virus ge - nomic variations. Mikrobiyol Bul 2015;49:625–35
  5. Tiryaki Y, Cetin Duran A, Ozcolpan OO. Distribution of hepatitis C virus genotypes in Aydın province. Viral Hepat J 2018;24:70–4
  6. Çizmeci Z. The distribution of hepatitis C virus genotypes in pa- tients with chronic hepatitis C infection. Türk Mikrobiyol Cem Derg 2016;46:27–32
  7. Şanlıdağ T, Akçalı S, Özbakkaloğlu B, Ertekin D, Distribution of hepatitis C virus genotypes in Manisa region, Turkey. Mikrobiyol Bul 2009;43:613–8
  8. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014;59:318–27
  9. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuo- ti C. Global epidemiology of hepatitis C virus infection: An up- date of the distribution and circulation of hepatitis C virus geno- types. World J Gastroenterol 2016;22:7824–40
  10. Tsukiyama-Kohara K, Kohara M. Hepatitis C virus: viral quasispe- cies and genotypes. Int J Mol Sci 2017;19:23
  11. Çekin Y, Gür N, Çekin AH, Altuğlu İ, Sertöz RY. Investigation of hepatitis C virus genotype distribution in patients with chronic hepatitis C infections in Antalya Training and Research Hospital, Turkey. Mikrobiyol Bul 2014;48:484–90 12. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epi- demiology and genotype distribution of the hepatitis C virus in- fection. J Hepatol 2014;61:S45–57
  12. Wilson EM, Rosenthal ES, Kattakuzhy S, Tang L, Kottilil S. Clinical laboratory testing in the era of directly acting antiviral therapies for hepatitis C. Clin Microbiol Rev 2017;30:23–42
  13. Çil T, Özekinci T, Göral V, Altıntaş A. Hepatitis C virus genotypes in the southeast region of Turkey. Turkiye Klinikleri Journal of Medi- cal Sciences 2007;27:496–500
  14. Aktaş O, Özbek A, Aydın H, Özkulekci MB. Distribution of HCV genotypes in